Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

UNKNOWN × Breast Neoplasms × Aspirin × Clear all

Phase

Status

Sponsor Class

OTHER 9 UNKNOWN 1 OTHER_GOV 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 1

Interventions

pyrotinib 4 Paclitaxel 4 Capecitabine 4 exemestane 3 Vinorelbine 3 Radiotherapy 3 Radiation Dose Hypofractionation 3 Fulvestrant 3 Epirubicin 3 Docetaxel 3 Carboplatin 3 apatinib 2 Neoadjuvant Therapy 2 Etoposide 2 Cyclophosphamide 2 Albumin-Bound Paclitaxel 2 toripalimab 1 pirarubicin 1 palbociclib 1 icaritin 1 anlotinib 1 Therapeutics 1 Standard of Care 1 Radiation 1 Pemetrexed 1 Methods 1 Letrozole 1 Granulocyte Colony-Stimulating Factor 1 Doxorubicin 1 Cisplatin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01431053 2013-03-13

Study of Aspirin and Exemestane as Adjuvant Treatment in Breast Cancer

ChineseAMS

Phase 2 Unknown

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡